The Recall Desk
ModerateFDA (Food)·F-1403-2018·Announced 2018-05-16

Energique Enervimin CNCR Focus Recalled as Unapproved New Drug

Grato Holdings, Inc. is recalling Energique Enervimin CNCR Focus dietary supplements because they are unapproved new drugs based on disease claims.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity level where the use of the product may cause temporary or medically reversible health consequences.

Plain-English summary

Grato Holdings, Inc. is recalling 767 bottles of Energique Enervimin CNCR Focus dietary supplements. The product was distributed by Energique Inc. in Woodbine, Iowa, and shipped to customers nationwide and in Canada.

The recall was initiated because the product is considered an unapproved new drug based on disease claims or routes of administration. The affected bottles have codes 50070340 and 55837004.

Consumers who purchased this product should stop using it and contact the recalling firm for further instructions.

The recalled product

Product
Energique, Dietary Supplement, Enervimin CNCR Focus, Dist. by Energique Inc.. Woodbine, IA 51579

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • 50070340
  • 55837004

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 4 recalled by Grato Holdings, Inc. under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →